Home/ Compounds/ GHRP-6

GHRP-6

Men's Health

Men's-health clinics treat GHRP-6 as one component in a layered hormonal optimisation framework. The first-generation GHRP, notable for strong appetite-stimulating effects alongside its GH-releasing action. The relevant questions for male users are: does it interact with the HPG axis, is it compatible with current TRT or HCG protocols, and what are its effects on prostate, hematocrit, and cardiovascular indices over a ~15-30 min-pharmacokinetics GHRP-6 cycle? The sections below address each.

Male Physiology Applications
HPG Axis SupportAndropauseErectile FunctionCardiovascular Health (Male)Muscle Mass
Category
Growth hormone releasing peptide
Standard Dose
100-300 mcg
Frequency
2-3x daily SubQ
Route
SubQ

Key Takeaways

  • Male-physiology lens: GHRP-6 is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations.
  • Mechanism: Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP.
  • Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel.
  • Male dose: 100-300 mcg 2-3x daily subq via subq; cycle 8-12 weeks.
  • Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.

Male Physiology Mechanism

Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. The male-physiology question is how this mechanism interacts with the HPG axis, with exogenous testosterone or HCG-paired protocols, and with prostate, hematocrit, and cardiovascular indices. The subsections below address HPG-axis interaction, TRT compatibility, body composition response, and prostate considerations for GHRP-6.

Compatibility with TRT and post-cycle protocols

For men currently on TRT or planning a post-cycle restart, GHRP-6 is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.

Male body composition and performance response

Male users typically respond to GHRP-6 on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.

Sexual function and prostate considerations

Where GHRP-6 alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.

Male Physiology Applications

HPG Axis Support

For hpg axis support in male users, GHRP-6 is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Hair Loss

Hair Loss in men responds to GHRP-6 with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.

TRT Compatibility

Where male users target trt compatibility, GHRP-6 is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.

Fat Loss (Male)

For fat loss (male) in male users, GHRP-6 is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.

Dosing Protocol

Goal Route Dose Cycle
Standard protocolSubQ100-300 mcg8–12 weeks on / 4 weeks off
Conservative starterSubQ60-300 mcg4–6 weeks initial cycle
Men's Health focusSubQ100-300 mcg2-3x daily SubQ
Maintenance phaseSubQ70-300 mcgOngoing with periodic pauses

Dose timing for GHRP-6 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

GHRP-6 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.

  • GHRP-6 + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with GHRP-6's mechanism in male physiology protocols.
  • GHRP-6 + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with GHRP-6's mechanism in male physiology protocols.
  • GHRP-6 + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with GHRP-6's mechanism in male physiology protocols.
  • GHRP-6 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with GHRP-6's mechanism in male physiology protocols.

Safety & Regulatory Status

WADA: Banned (S2) FDA: Unapproved

Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable.

Lens-specific safety considerations for male physiology use of GHRP-6: Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

GHRP-6 vs Related Peptides

Compound Profile Onset Best For
GHRP-6Growth hormone releasing peptide~15-30 minMen's Health
KisspeptinHypothalamic upstream regulator of GnRH~28 min IVThe upstream master regulator of GnRH neurons — driving the entire HPG axis from above
Gonadorelin (GnRH)Hypothalamic decapeptide~2-4 minThe natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy
PT-141Melanocortin receptor agonist~2-3 hrAn MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women

Frequently Asked Questions

How does GHRP-6 affect the HPG axis?
GHRP-6's effect on the male HPG axis depends on its primary pharmacology. Direct HPG engagement is not the principal mechanism, but indirect effects via inflammation, metabolic status, or hepatic SHBG can produce hormone shifts that warrant baseline and follow-up labs. A comprehensive baseline hormone panel before starting and 6–8 week re-check is the standard approach.
What blood work should I run on this protocol?
Standard male protocol baseline: total and free testosterone, LH, FSH, estradiol (sensitive), prolactin, SHBG, fasting glucose, HbA1c, hsCRP, lipid panel, CBC, CMP. Follow-up at week 6–8 with the same panel. Add IGF-1 for any GH-axis compound. Add PSA for men over 40.
Can I use GHRP-6 during a cut?
Yes, and several compounds in this class are specifically protective of lean mass in caloric deficit. The dose-timing relative to training and the protein intake matter more than the absolute dose. Cardiovascular and metabolic monitoring continues to apply.
Best time of day to dose for male users?
The pragmatic schedule is morning fasted for compounds engaging the GH axis (preserving the natural overnight pulse), evening for compounds supporting sleep, and PRN for compounds with acute effects (PT-141, etc.). The schedule should fit the user's daily reality more than the textbook ideal.
What is GHRP-6?
GHRP-6 (also known as Growth Hormone Releasing Peptide 6) is a 6-residue growth hormone releasing peptide with a molecular weight of 873 Da and a plasma half-life of ~15-30 min. Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. The compound is studied primarily in the male physiology domain for the applications outlined above.
What should I look for in GHRP-6 sourcing and quality?
Acceptable GHRP-6 certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching 873 Da, endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.
Clinical Protocol

Start a GHRP-6 Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified GHRP-6 and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight
873 Da
Sequence length
6 aa
Half-life
~15-30 min
WADA
Banned (S2)
FDA
Unapproved
Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for GHRP-6 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for GHRP-6

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

HIPAA Compliant · GMP Certified · Physician Supervised